Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians
Endocrinology, Diabetes & Metabolism · 2023
DOI: 10.1002/edm2.398 ↗At a glance
Journal article in Endocrinology, Diabetes & Metabolism, 2023. Written by Winy Widjaja and 6 co-authors. Institution: Surgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia. Major MEDLINE topics: Thyroid Neoplasms. Cited 1 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Introduction
De‐escalated treatment of hemithyroidectomy without radioactive iodine (RAI) is now accepted for patients with low‐risk, well‐differentiated thyroid cancer (WDTC). The benefit of long‐term follow‐up care remains controversial. This study aims to describe parameters associated with less than total thyroidectomy, and discharge from specialist follow‐up in patients with low‐risk WDTC in Australia.
Methods
An online survey was distributed to Australian members of Endocrine Society of Australia, Australian and New Zealand Endocrine Surgeons, and Australian Society of Otolaryngology, Head and Neck Surgery. Clinicians completed a survey of management and follow‐up care preferences for four clinical vignettes (all low‐risk WDTC).
Results
119 clinicians (48% endocrinologists, 55% male) answered at least one question. The majority (59%) of respondents recommended less than total thyroidectomy and omission of RAI in patients with WDTC 90% of clinicians would continue specialist follow‐up for at least 5 years. The majority of clinicians felt that patients experienced disproportionate fear of recurrence and were reassured by follow‐up. After multivariable analysis, clinicians who participated in multidisciplinary teams (MDTs) were more likely to choose de‐escalated care for both initial treatment ( p = .005) and follow‐up care (>5 years, p = .05).
Conclusion
Clinician attitudes captured by this survey reflect recent changes in guidelines towards hemithyroidectomy for low‐risk WDTC, particularly amongst MDT attendees. There is a need to further examine the impact of de‐escalated care on fear of recurrence and quality of life in thyroid cancer survivors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Surgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia.
- Department of Endocrinology, John Hunter Hospital, Newcastle, New South Wales, Australia.
- University of Newcastle, Newcastle, New South Wales, Australia.
- Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
ORCID profiles: Winy Widjaja, Christine J O'Neill
Cite
APA
Widjaja, W., Rowe, C. W., Oldmeadow, C., Cope, D., Fradgley, E. A., Paul, C., & O'Neill, C. J. (2023). Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.398
Vancouver
Widjaja W, Rowe CW, Oldmeadow C, Cope D, Fradgley EA, Paul C, et al. Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians. Endocrinology, Diabetes & Metabolism. 2023. doi:10.1002/edm2.398
BibTeX
@article{Widjaja2023,
author = {Widjaja, Winy and Rowe, Christopher W and Oldmeadow, Christopher and Cope, Daron and Fradgley, Elizabeth A and Paul, Christine and O'Neill, Christine J},
title = {Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2023},
doi = {10.1002/edm2.398}
}
EUVIMED